Web Analytics

3 Latest Announced Rounds

  • $1,000,000
    Pre-Seed

    3 Investors

    Technology, Information and Internet
    Jun 27th, 2025
  • $12,000,000
    Series A
    Mental Health Care
    Jun 27th, 2025
  • $8,000,000
    Seed

    2 Investors

    Software Development
    Jun 27th, 2025
$1,962.72M Raised in 58 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Microplate Dx Limited

start up
United Kingdom - Glasgow, Lanarkshire
  • 12/09/2023
  • Seed
  • $3,117,000

Microplate Dx Limited specialises in rapid antibiotic susceptibility testing diagnostics, enabling clinicians, at the point-of-care, to confidently select the best choice of antibiotic to treat a patient’s infection in a matter of minutes, significantly quicker than the current gold standard technology which takes at least 2 days. Our award-wining, platform diagnostic test helps reduce the major global health threat of antimicrobial resistance and ultimately, saves lives.


Related People

Stuart HannahFounder

Stuart Hannah United Kingdom - Greater Glasgow Area

CEO - Microplate Dx Limited.

Developing a rapid, cost-effective, direct-from-sample, antibiotic susceptibility test, which quickly identifies the best choice of antibiotic for a particular infection in minutes, significantly quicker than the current gold standard of days.